Profiel
Donald Pearl is currently the Director at Child Neurology Foundation.
Prior to this, he was the Chief Executive Officer at Aruene Corp.
in 2020 and the Vice President-Neurology at Ipsen Biopharmaceuticals, Inc. from 2014 to 2019.
Actieve functies van Donald Pearl
Bedrijven | Functie | Begin |
---|---|---|
Child Neurology Foundation | Directeur/Bestuurslid | - |
Eerdere bekende functies van Donald Pearl
Bedrijven | Functie | Einde |
---|---|---|
Aruene Corp.
Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Algemeen Directeur | 01-08-2020 |
Ipsen Biopharmaceuticals, Inc. | Corporate Officer/Principal | 01-04-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Aruene Corp.
Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Health Technology |
Child Neurology Foundation | |
Ipsen Biopharmaceuticals, Inc. |